Butyrate-modified liposomes target the delivery of itaconic acid to modulate the Th17/Treg cell balance through epigenetic reprogramming, improving primary biliary cholangitis
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP640157
下载链接
链接失效反馈官方服务：
资源简介：
Primary biliary cholangitis (PBC) is a chronic autoimmune disease. This study aims to design itaconic acid (IA)-loaded butyrate (Bu)-modified lipid nanoparticles (LNP-Bu@IA) for targeted delivery of IA, modulate the Th17/Treg cell balance through metabolic and epigenetic reprogramming, improve PBC, and provide a novel strategy for its treatment
创建时间：
2025-11-06
